Results 171 to 180 of about 56,171 (221)

Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein. [PDF]

Mol Neurodegener
Liang J, Li R, Wong G, Huang X.
europepmc   +1 more source

Reply: Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes. [PDF]

Alzheimers Dement
Hannaway N, Zarkali A, Bhome R, Dobreva I, Thomas GE, Veleva E, Belio IG, Tucker K, Heslegrave A, Zetterberg H, Weil RS.   +10 more
europepmc   +1 more source

Lewy body dementia

, 2012
openaire   +1 more source

Lewy body dementia

, 2014
openaire   +1 more source

Diffusion tensor imaging analysis along the perivascular space suggests impaired glymphatic clearance in Lewy body dementia subtypes

Hannaway N, Zarkali A, Bhome R, Dobreva I, Kalam S, Thomas GE, Dymerska B, Gorostiaga Belio I, Tucker K, Heslegrave A, Zetterberg H, Weil RS.   +11 more
europepmc   +1 more source

Interaction between alpha-synuclein and tau pathologies in a mouse model of Lewy body dementia [PDF]

Jiang, Hong
core